"These data add to the increasing body of evidence supporting use of REGEN-COV to prevent COVID-19 in uninfected individuals," said Regeneron's chief scientific officer George Yancopolous.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback